Communiqués de presse
Archives
VitamFero and Oniris have signed an agreement to study the efficacy of a vaccine candidate against neosporosis
2011/12/06
VitamFero, a biotechnology firm in the Genopole cluster that develops novel vaccines to prevent specific parasitic diseases, and Oniris, an institute of higher education and specialized research, particularly in human and animal health, announced the signing of a services contract to study the efficacy of a new generation vaccine candidate against bovine (cattle) neosporosis.
In order to receive
Genopole® press releases®,
please provide your coordinates
to Press Service
